BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 10430026)

  • 21. Clinical gene therapy using recombinant adeno-associated virus vectors.
    Mueller C; Flotte TR
    Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors.
    Clark KR; Voulgaropoulou F; Johnson PR
    Gene Ther; 1996 Dec; 3(12):1124-32. PubMed ID: 8986439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.
    During MJ; Leone P
    Clin Neurosci; 1995-1996; 3(5):292-300. PubMed ID: 8914796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular trafficking of adeno-associated viral vectors.
    Ding W; Zhang L; Yan Z; Engelhardt JF
    Gene Ther; 2005 Jun; 12(11):873-80. PubMed ID: 15829993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adeno-associated viral vectors: background and technical aspects.
    Snoeck HW; Tao W; Klotman ME
    Exp Nephrol; 1997; 5(6):514-20. PubMed ID: 9438181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AAV-directed muscular dystrophy gene therapy.
    Tang Y; Cummins J; Huard J; Wang B
    Expert Opin Biol Ther; 2010 Mar; 10(3):395-408. PubMed ID: 20132060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production.
    Li C; Samulski RJ
    Virology; 2005 Apr; 335(1):10-21. PubMed ID: 15823602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.
    Couto LB
    Semin Thromb Hemost; 2004 Apr; 30(2):161-71. PubMed ID: 15118928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current development of adeno-associated viral vectors.
    Romano G
    Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach.
    Zhang X; Li CY
    Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Production and purification of helper free recombinant adeno-associated virus 2].
    Li GL; Wang RZ; Wang X; Dou WC; Zhang B; Tian SQ; Ren ZY; Su CB
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1255-8. PubMed ID: 12930642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adeno-associated virus (AAV) as a vector for gene transfer into glial cells of the human central nervous system.
    Tenenbaum L; Darling JL; Hooghe-Peters E
    Gene Ther; 1994; 1 Suppl 1():S80. PubMed ID: 8542426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: recent advances and potential clinical applications.
    Hallek M; Wendtner CM
    Cytokines Mol Ther; 1996 Jun; 2(2):69-79. PubMed ID: 9384691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.
    Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A
    Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation?
    Yang ZF; Wu XB; Tsui TY; Hou YD; Luk JM; Fan ST
    Liver Transpl; 2003 Apr; 9(4):411-20. PubMed ID: 12682895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tendon healing in vitro: bFGF gene transfer to tenocytes by adeno-associated viral vectors promotes expression of collagen genes.
    Wang XT; Liu PY; Xin KQ; Tang JB
    J Hand Surg Am; 2005 Nov; 30(6):1255-61. PubMed ID: 16344185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High throughput production, screening and analysis of adeno-associated viral vectors.
    Drittanti L; Rivet C; Manceau P; Danos O; Vega M
    Gene Ther; 2000 Jun; 7(11):924-9. PubMed ID: 10849551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designing gene delivery vectors for cardiovascular gene therapy.
    Baker AH
    Prog Biophys Mol Biol; 2004; 84(2-3):279-99. PubMed ID: 14769440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.